Estrella Immunopharma ESLA Q1 2026 Earnings WiderThanExpected Loss Triggers Modest Stock Gain ADC Therapeutics Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues DRH Q1 2026 Earnings Strong EPS Beat Amidst Operational Discipline Hyperfine Inc HYPR Q1 2026 Earnings Narrower Loss Beats Estimates Stock Declines Amid Uncertain Revenue Outlook MKSI Q1 2026 Earnings EPS Beat Drives 4 Stock Surge Amid Strong Operational Execution RRC Q1 2026 Earnings EPS Beats Estimates by 19 Amid Operational Efficiency